| HWM |
Report |
Revenue |
BEAT |
pred ~$2.455B vs. cons $2.427B |
MEDIUM |
| HWM |
Report |
Adjusted EBITDA |
BEAT |
pred ~$785M vs. cons $772M |
MEDIUM |
| HWM |
Report |
Operating diluted EPS |
BEAT |
pred ~$1.270 vs. cons $1.248 |
MEDIUM |
| HWM |
Guide |
FY26 Revenue |
UNCHANGED |
guide ~$9.75B vs. cons $9.760B |
MEDIUM |
| HWM |
Guide |
FY26 Operating EPS |
UNCHANGED |
guide ~$5.05 vs. cons $5.054 |
MEDIUM |
| HWM |
Guide |
Q3 Operating EPS |
BETTER |
guide ~$1.28 vs. cons $1.265 |
MEDIUM |
| HWM |
Return |
Day-1 residual (stock − beta × S&P 500) |
+3.5% |
— |
LOW |
| HWM |
Return |
5-day cumulative residual |
+4.5% (FOLLOW-THROUGH) |
FOLLOW-THROUGH — modest revisions, but capped by softer implied Q4 |
LOW |